Reply to Johansson 'Treatment with BRICHOS domain helps to clarify issues with Alzheimer mouse models'

Luciano D'Adamio

doi:10.1038/s44321-024-00042-0

Reply to Johansson 'Treatment with BRICHOS domain helps to clarify issues with Alzheimer mouse models'

EMBO Mol Med. 2024 Apr;16(4):717-719. doi: 10.1038/s44321-024-00042-0. Epub 2024 Mar 13.

Author

Luciano D'Adamio¹

Affiliation

¹ Department of Pharmacology, Physiology & Neuroscience New Jersey Medical School, Brain Health Institute, Jacqueline Krieger Klein Center in Alzheimer's Disease and Neurodegeneration Research, Rutgers, The State University of New Jersey, 205 South Orange Ave, Newark, NJ, 07103, USA. [email protected].

Abstract

This correspondence is a reply to correspondence from Dr. Jan Johansson on the utility of BRICHOS domains in understanding pathology in Alzheimer’s disease mouse models.

Publication types

Letter

MeSH terms

Alzheimer Disease* / drug therapy
Amyloid
Amyloid beta-Peptides
Animals
Mice

Substances

Amyloid
Amyloid beta-Peptides

Grants and funding

RF1 AG064821/AG/NIA NIH HHS/United States